Clinical Trial Update: Multidisciplinary Study of Novel NMDA Modulation for Neurodegenerative Disorder [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating a novel NMDA modulation approach for Parkinson's disease with dementia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease with Dementia

Snippet

Sponsor: China Medical University Hospital | Conditions: Parkinson's Disease With Dementia | Phase 2 | Status: COMPLETED